Brookfield Corp’s GSK GSK Stock Holding History

Brookfield Corp’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-644,249	Closed	-$23M	–	291
2023 Q2	$23M	Buy	644,249 +39,429	+7%	+$1.41M	0.09%	82
2023 Q1	$21.5M	Buy	604,820 +570,527	+1,664%	+$20M	0.08%	99
2022 Q4	$1.21M	Sell	34,293 -43	-0.1%	-$1.43K	﹤0.01%	480
2022 Q3	$1.01M	Sell	34,336 -346,516	-91%	-$13.1M	﹤0.01%	532
2022 Q2	$20.7M	Buy	380,852 +135,647	+55%	+$7.49M	0.09%	90
2022 Q1	$13.4M	Buy	245,205 +166,192	+210%	+$9.03M	0.05%	125
2021 Q4	$4.36M	Buy	+79,013	New	+$4.11M	0.02%	238

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Royal Bank of Canada

Royal Bank of Canada Toronto, Ontario, Canada $528B AUM 27.57% 1-Year Est. Return

Arrowstreet Capital

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return